"Podophyllotoxin" - Books

Result Filters

Results: 1 to 20 of 27 books (193 items)

<< First< Prev

Page of 2

Select item 42313801.

Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

Thurgar E, Barton S, Karner C, et al.

Southampton (UK): NIHR Journals Library; 2016 Mar. (Health Technology Assessment, No. 20.24.)

Top results in this book Table of Contents

Select item 50765382.

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Gilson R, Nugent D, Bennett K, et al.

Southampton (UK): NIHR Journals Library; 2020 Sep. (Health Technology Assessment, No. 24.47.)

Top results in this book Table of Contents

Select item 44036683.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 48538164.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 31303365.

Dietary Supplements: A Framework for Evaluating Safety.

Institute of Medicine (US) and National Research Council (US) Committee on the Framework for Evaluating the Safety of Dietary Supplements.

Washington (DC): National Academies Press (US); 2005.

Top results in this book Table of Contents

Select item 55562766.

Prevention and Management of Human Papillomavirus Infection in Adults With HIV [Internet].

Shah M, Timoney MT, Atrio JM, et al.

Baltimore (MD): Johns Hopkins University; 2022 Nov.

Top results in this book Table of Contents

Select item 46060727.

Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet].

Banerjee S, Kaunelis D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep 25.

Top results in this book Table of Contents

Select item 16686908.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 40940969.

Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults.

Geneva: World Health Organization; 2014.

Top results in this book Table of Contents

Select item 412963810.

Human Papillomaviruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90.)

Top results in this book Table of Contents

Select item 447303011.

The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis.

Wailoo A, Hock ES, Stevenson M, et al.

Southampton (UK): NIHR Journals Library; 2017 Nov. (Health Technology Assessment, No. 21.71.)

Top results in this book Table of Contents

Select item 423536612.

CADTH Report / Project in Briefs [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011-2021.

Top results in this book Table of Contents

Select item 316823813.

Biodiversity.

Wilson EO, Peter FM, editors.

Washington (DC): National Academies Press (US); 1988.

Top results in this book Table of Contents

Select item 556437614.

$Tisagenlecleucel (Kymriah): CADTH Reimbursement Review: Therapeutic area: Relapsed or refractory follicular lymphoma [Internet].$

Tisagenlecleucel (Kymriah): CADTH Reimbursement Review: Therapeutic area: Relapsed or refractory follicular lymphoma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.

Top results in this book Table of Contents

Select item 548775215.

Amivantamab (Rybrevant): CADTH Reimbursement Review: Therapeutic area: Non–small cell lung cancer [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.

Top results in this book Table of Contents

Select item 447027416.

State of the World's Plants 2017.

Willis KJ, editor.

London (UK): Royal Botanic Gardens, Kew; 2017.

Top results in this book Table of Contents

Select item 438190017.

Human Papillomaviruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1995. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 64.)

Top results in this book Table of Contents

Select item 434989618.

Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2000. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 76.)

Top results in this book Table of Contents

Select item 336274419.

Systematic review of treatments for atopic eczema.

Hoare C, Li Wan Po A, Williams H.

Southampton (UK): NIHR Journals Library; 2000 Dec. (Health Technology Assessment, No. 04.37.)

Top results in this book Table of Contents

Select item 521860020.

Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].

Gidengil C, Goetz MB, Maglione M, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)

Top results in this book Table of Contents

<< First< Prev

Page of 2

Next >Last >>

Supplemental Content

Images search in Bookshelf

FIGURE 32

Multiple cost-effectiveness acceptability curves for the scenario analysis including podophyllotoxin 0.5% cream as a proxy for podophyllotoxin 0.15% cream.

Assessment of cost-effectiveness.

Thurgar E, Barton S, Karner C, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Mar.
FIGURE 23

Cost-effectiveness plane presenting the incremental costs and QALYs associated with CO₂ laser therapy followed by podophyllotoxin 0.5% solution vs. podophyllotoxin 0.5% solution followed by CO₂ laser therapy.

Assessment of cost-effectiveness.

Thurgar E, Barton S, Karner C, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Mar.
FIGURE 21

Cost-effectiveness plane presenting the incremental costs and QALYs associated with podophyllotoxin 0.5% solution followed by surgery vs. podophyllotoxin 0.5% solution followed by CO₂ laser therapy.

Assessment of cost-effectiveness.

Thurgar E, Barton S, Karner C, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Mar.
FIGURE 34

Top five parameters for which the model results were most sensitive for the comparison of CO₂ laser therapy followed by podophyllotoxin 0.5% solution with podophyllotoxin 0.5% solution followed by CO₂ laser therapy.

Assessment of cost-effectiveness.

Thurgar E, Barton S, Karner C, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Mar.